These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 12410253)

  • 1. Celebrating diversity and mimicking maturation.
    Presta LG
    Nat Biotechnol; 2002 Nov; 20(11):1096-7. PubMed ID: 12410253
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines.
    Cumbers SJ; Williams GT; Davies SL; Grenfell RL; Takeda S; Batista FD; Sale JE; Neuberger MS
    Nat Biotechnol; 2002 Nov; 20(11):1129-34. PubMed ID: 12379869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of two anti-CD19 single chain Fv fragments for targeting of liposomes to CD19-expressing cells.
    Cheng WW; Das D; Suresh M; Allen TM
    Biochim Biophys Acta; 2007 Jan; 1768(1):21-9. PubMed ID: 17046711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of peptidic mimics of digoxin from phage-displayed peptide libraries by anti-digoxin antibodies.
    Ball WJ; Wang Z; Malik B; Kasturi R; Dey P; Short MK; Margolies MN
    J Mol Biol; 2000 Aug; 301(1):101-15. PubMed ID: 10926495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity maturation of monoclonal antibodies by multi-site-directed mutagenesis.
    Kim HY; Stojadinovic A; Izadjoo MJ
    Methods Mol Biol; 2014; 1131():407-20. PubMed ID: 24515479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of antibody affinity by a non-contact residue.
    Schillbach JF; Near RI; Bruccoleri RE; Haber E; Jeffrey PD; Novotny J; Sheriff S; Margolies MN
    Protein Sci; 1993 Feb; 2(2):206-14. PubMed ID: 8443598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for affinity maturation of an antibody with high evolvability to (4-hydroxy-3-nitrophenyl) acetyl hapten.
    Furukawa K; Shimizu T; Murakami A; Kono R; Nakagawa M; Sagawa T; Yamato I; Azuma T
    Mol Immunol; 2007 Mar; 44(9):2436-45. PubMed ID: 17118452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous surface display and secretion of proteins from mammalian cells facilitate efficient in vitro selection and maturation of antibodies.
    Horlick RA; Macomber JL; Bowers PM; Neben TY; Tomlinson GL; Krapf IP; Dalton JL; Verdino P; King DJ
    J Biol Chem; 2013 Jul; 288(27):19861-9. PubMed ID: 23689374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
    Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
    J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of blood serum polyreactive immunoglobulins on serum antibody affinity determination].
    Bobrovnik SA; Demchenko MA; Komisarenko SV
    Ukr Biokhim Zh (1999); 2010; 82(1):62-9. PubMed ID: 20684229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of a murine monoclonal anti-DNA antibody to Raji cells. Implications for the interpretation of the Raji cell assay for immune complexes.
    Tron F; Jacob L; Bach JF
    Eur J Immunol; 1984 Mar; 14(3):283-6. PubMed ID: 6368250
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
    Sharifi J; Khawli LA; Hu P; King S; Epstein AL
    Hybrid Hybridomics; 2001; 20(5-6):305-12. PubMed ID: 11839248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.
    Julian MC; Lee CC; Tiller KE; Rabia LA; Day EK; Schick AJ; Tessier PM
    Protein Eng Des Sel; 2015 Oct; 28(10):339-50. PubMed ID: 26386257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
    Press OW; Farr AG; Borroz KI; Anderson SK; Martin PJ
    Cancer Res; 1989 Sep; 49(17):4906-12. PubMed ID: 2667754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of anti-DNA antibodies.
    Stevenson FK; Silverman GJ
    Lupus; 1997; 6(3):321-3. PubMed ID: 9296777
    [No Abstract]   [Full Text] [Related]  

  • 18. Man-made antibodies.
    Winter G; Milstein C
    Nature; 1991 Jan; 349(6307):293-9. PubMed ID: 1987490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of CAT-354, a therapeutic antibody directed against interleukin-13, using ribosome display.
    Thom G; Minter R
    Methods Mol Biol; 2012; 805():393-401. PubMed ID: 22094818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the affinity maturation of antibody 48G7.
    Yang PL; Schultz PG
    J Mol Biol; 1999 Dec; 294(5):1191-201. PubMed ID: 10600377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.